1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Factor VIII Deficiency Treatment Market Size Growth Rate by Type: 2017 VS 2021 VS 2028 1.2.2 Hemophilia A Drugs 1.2.3 Hemophilia A Inhibitors Treatment 1.2.4 Von Willebrand Disease Treatment 1.3 Market by Application 1.3.1 Global Factor VIII Deficiency Treatment Market Share by Application: 2017 VS 2021 VS 2028 1.3.2 Hospitals 1.3.3 Clinics 1.3.4 Other 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global Factor VIII Deficiency Treatment Market Perspective (2017-2028) 2.2 Factor VIII Deficiency Treatment Growth Trends by Region 2.2.1 Factor VIII Deficiency Treatment Market Size by Region: 2017 VS 2021 VS 2028 2.2.2 Factor VIII Deficiency Treatment Historic Market Size by Region (2017-2022) 2.2.3 Factor VIII Deficiency Treatment Forecasted Market Size by Region (2023-2028) 2.3 Factor VIII Deficiency Treatment Market Dynamics 2.3.1 Factor VIII Deficiency Treatment Industry Trends 2.3.2 Factor VIII Deficiency Treatment Market Drivers 2.3.3 Factor VIII Deficiency Treatment Market Challenges 2.3.4 Factor VIII Deficiency Treatment Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Factor VIII Deficiency Treatment Players by Revenue 3.1.1 Global Top Factor VIII Deficiency Treatment Players by Revenue (2017-2022) 3.1.2 Global Factor VIII Deficiency Treatment Revenue Market Share by Players (2017-2022) 3.2 Global Factor VIII Deficiency Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 3.3 Players Covered: Ranking by Factor VIII Deficiency Treatment Revenue 3.4 Global Factor VIII Deficiency Treatment Market Concentration Ratio 3.4.1 Global Factor VIII Deficiency Treatment Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Factor VIII Deficiency Treatment Revenue in 2021 3.5 Factor VIII Deficiency Treatment Key Players Head office and Area Served 3.6 Key Players Factor VIII Deficiency Treatment Product Solution and Service 3.7 Date of Enter into Factor VIII Deficiency Treatment Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Factor VIII Deficiency Treatment Breakdown Data by Type 4.1 Global Factor VIII Deficiency Treatment Historic Market Size by Type (2017-2022) 4.2 Global Factor VIII Deficiency Treatment Forecasted Market Size by Type (2023-2028) 5 Factor VIII Deficiency Treatment Breakdown Data by Application 5.1 Global Factor VIII Deficiency Treatment Historic Market Size by Application (2017-2022) 5.2 Global Factor VIII Deficiency Treatment Forecasted Market Size by Application (2023-2028) 6 North America 6.1 North America Factor VIII Deficiency Treatment Market Size (2017-2028) 6.2 North America Factor VIII Deficiency Treatment Market Size by Country (2017-2022) 6.3 North America Factor VIII Deficiency Treatment Market Size by Country (2023-2028) 6.4 United States 6.5 Canada 7 Europe 7.1 Europe Factor VIII Deficiency Treatment Market Size (2017-2028) 7.2 Europe Factor VIII Deficiency Treatment Market Size by Country (2017-2022) 7.3 Europe Factor VIII Deficiency Treatment Market Size by Country (2023-2028) 7.4 Germany 7.5 France 7.6 U.K. 7.7 Italy 7.8 Russia 7.9 Nordic Countries 8 Asia-Pacific 8.1 Asia-Pacific Factor VIII Deficiency Treatment Market Size (2017-2028) 8.2 Asia-Pacific Factor VIII Deficiency Treatment Market Size by Country (2017-2022) 8.3 Asia-Pacific Factor VIII Deficiency Treatment Market Size by Country (2023-2028) 8.4 China 8.5 Japan 8.6 South Korea 8.7 Southeast Asia 8.8 India 8.9 Australia 9 Latin America 9.1 Latin America Factor VIII Deficiency Treatment Market Size (2017-2028) 9.2 Latin America Factor VIII Deficiency Treatment Market Size by Country (2017-2022) 9.3 Latin America Factor VIII Deficiency Treatment Market Size by Country (2023-2028) 9.4 Mexico 9.5 Brazil 10 Middle East & Africa 10.1 Middle East & Africa Factor VIII Deficiency Treatment Market Size (2017-2028) 10.2 Middle East & Africa Factor VIII Deficiency Treatment Market Size by Country (2017-2022) 10.3 Middle East & Africa Factor VIII Deficiency Treatment Market Size by Country (2023-2028) 10.4 Turkey 10.5 Saudi Arabia 10.6 UAE 11 Key Players Profiles 11.1 Pfizer 11.1.1 Pfizer Company Detail 11.1.2 Pfizer Business Overview 11.1.3 Pfizer Factor VIII Deficiency Treatment Introduction 11.1.4 Pfizer Revenue in Factor VIII Deficiency Treatment Business (2017-2022) 11.1.5 Pfizer Recent Development 11.2 Takeda 11.2.1 Takeda Company Detail 11.2.2 Takeda Business Overview 11.2.3 Takeda Factor VIII Deficiency Treatment Introduction 11.2.4 Takeda Revenue in Factor VIII Deficiency Treatment Business (2017-2022) 11.2.5 Takeda Recent Development 11.3 Bayer HealthCare 11.3.1 Bayer HealthCare Company Detail 11.3.2 Bayer HealthCare Business Overview 11.3.3 Bayer HealthCare Factor VIII Deficiency Treatment Introduction 11.3.4 Bayer HealthCare Revenue in Factor VIII Deficiency Treatment Business (2017-2022) 11.3.5 Bayer HealthCare Recent Development 11.4 CSL 11.4.1 CSL Company Detail 11.4.2 CSL Business Overview 11.4.3 CSL Factor VIII Deficiency Treatment Introduction 11.4.4 CSL Revenue in Factor VIII Deficiency Treatment Business (2017-2022) 11.4.5 CSL Recent Development 11.5 Grifols 11.5.1 Grifols Company Detail 11.5.2 Grifols Business Overview 11.5.3 Grifols Factor VIII Deficiency Treatment Introduction 11.5.4 Grifols Revenue in Factor VIII Deficiency Treatment Business (2017-2022) 11.5.5 Grifols Recent Development 11.6 Novo Nordisk 11.6.1 Novo Nordisk Company Detail 11.6.2 Novo Nordisk Business Overview 11.6.3 Novo Nordisk Factor VIII Deficiency Treatment Introduction 11.6.4 Novo Nordisk Revenue in Factor VIII Deficiency Treatment Business (2017-2022) 11.6.5 Novo Nordisk Recent Development 11.7 F. Hoffmann-La Roche 11.7.1 F. Hoffmann-La Roche Company Detail 11.7.2 F. Hoffmann-La Roche Business Overview 11.7.3 F. Hoffmann-La Roche Factor VIII Deficiency Treatment Introduction 11.7.4 F. Hoffmann-La Roche Revenue in Factor VIII Deficiency Treatment Business (2017-2022) 11.7.5 F. Hoffmann-La Roche Recent Development 11.8 Kedrion 11.8.1 Kedrion Company Detail 11.8.2 Kedrion Business Overview 11.8.3 Kedrion Factor VIII Deficiency Treatment Introduction 11.8.4 Kedrion Revenue in Factor VIII Deficiency Treatment Business (2017-2022) 11.8.5 Kedrion Recent Development 11.9 Octapharma 11.9.1 Octapharma Company Detail 11.9.2 Octapharma Business Overview 11.9.3 Octapharma Factor VIII Deficiency Treatment Introduction 11.9.4 Octapharma Revenue in Factor VIII Deficiency Treatment Business (2017-2022) 11.9.5 Octapharma Recent Development 11.10 Biogen Idec 11.10.1 Biogen Idec Company Detail 11.10.2 Biogen Idec Business Overview 11.10.3 Biogen Idec Factor VIII Deficiency Treatment Introduction 11.10.4 Biogen Idec Revenue in Factor VIII Deficiency Treatment Business (2017-2022) 11.10.5 Biogen Idec Recent Development 11.11 BioMarin Pharmaceutical 11.11.1 BioMarin Pharmaceutical Company Detail 11.11.2 BioMarin Pharmaceutical Business Overview 11.11.3 BioMarin Pharmaceutical Factor VIII Deficiency Treatment Introduction 11.11.4 BioMarin Pharmaceutical Revenue in Factor VIII Deficiency Treatment Business (2017-2022) 11.11.5 BioMarin Pharmaceutical Recent Development 11.12 Sangamo Therapeutics 11.12.1 Sangamo Therapeutics Company Detail 11.12.2 Sangamo Therapeutics Business Overview 11.12.3 Sangamo Therapeutics Factor VIII Deficiency Treatment Introduction 11.12.4 Sangamo Therapeutics Revenue in Factor VIII Deficiency Treatment Business (2017-2022) 11.12.5 Sangamo Therapeutics Recent Development 11.13 Spark Therapeutics 11.13.1 Spark Therapeutics Company Detail 11.13.2 Spark Therapeutics Business Overview 11.13.3 Spark Therapeutics Factor VIII Deficiency Treatment Introduction 11.13.4 Spark Therapeutics Revenue in Factor VIII Deficiency Treatment Business (2017-2022) 11.13.5 Spark Therapeutics Recent Development 11.14 Swedish Orphan Biovitrum 11.14.1 Swedish Orphan Biovitrum Company Detail 11.14.2 Swedish Orphan Biovitrum Business Overview 11.14.3 Swedish Orphan Biovitrum Factor VIII Deficiency Treatment Introduction 11.14.4 Swedish Orphan Biovitrum Revenue in Factor VIII Deficiency Treatment Business (2017-2022) 11.14.5 Swedish Orphan Biovitrum Recent Development 11.15 Uniqure NV 11.15.1 Uniqure NV Company Detail 11.15.2 Uniqure NV Business Overview 11.15.3 Uniqure NV Factor VIII Deficiency Treatment Introduction 11.15.4 Uniqure NV Revenue in Factor VIII Deficiency Treatment Business (2017-2022) 11.15.5 Uniqure NV Recent Development 11.16 Amarna Therapeutics 11.16.1 Amarna Therapeutics Company Detail 11.16.2 Amarna Therapeutics Business Overview 11.16.3 Amarna Therapeutics Factor VIII Deficiency Treatment Introduction 11.16.4 Amarna Therapeutics Revenue in Factor VIII Deficiency Treatment Business (2017-2022) 11.16.5 Amarna Therapeutics Recent Development 11.17 Dimension Therapeutics 11.17.1 Dimension Therapeutics Company Detail 11.17.2 Dimension Therapeutics Business Overview 11.17.3 Dimension Therapeutics Factor VIII Deficiency Treatment Introduction 11.17.4 Dimension Therapeutics Revenue in Factor VIII Deficiency Treatment Business (2017-2022) 11.17.5 Dimension Therapeutics Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details

List of Tables Table 1. Global Factor VIII Deficiency Treatment Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028 Table 2. Key Players of Hemophilia A Drugs Table 3. Key Players of Hemophilia A Inhibitors Treatment Table 4. Key Players of Von Willebrand Disease Treatment Table 5. Global Factor VIII Deficiency Treatment Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028 Table 6. Global Factor VIII Deficiency Treatment Market Size by Region (US$ Million): 2017 VS 2021 VS 2028 Table 7. Global Factor VIII Deficiency Treatment Market Size by Region (2017-2022) & (US$ Million) Table 8. Global Factor VIII Deficiency Treatment Market Share by Region (2017-2022) Table 9. Global Factor VIII Deficiency Treatment Forecasted Market Size by Region (2023-2028) & (US$ Million) Table 10. Global Factor VIII Deficiency Treatment Market Share by Region (2023-2028) Table 11. Factor VIII Deficiency Treatment Market Trends Table 12. Factor VIII Deficiency Treatment Market Drivers Table 13. Factor VIII Deficiency Treatment Market Challenges Table 14. Factor VIII Deficiency Treatment Market Restraints Table 15. Global Factor VIII Deficiency Treatment Revenue by Players (2017-2022) & (US$ Million) Table 16. Global Factor VIII Deficiency Treatment Market Share by Players (2017-2022) Table 17. Global Top Factor VIII Deficiency Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Factor VIII Deficiency Treatment as of 2021) Table 18. Ranking of Global Top Factor VIII Deficiency Treatment Companies by Revenue (US$ Million) in 2021 Table 19. Global 5 Largest Players Market Share by Factor VIII Deficiency Treatment Revenue (CR5 and HHI) & (2017-2022) Table 20. Key Players Headquarters and Area Served Table 21. Key Players Factor VIII Deficiency Treatment Product Solution and Service Table 22. Date of Enter into Factor VIII Deficiency Treatment Market Table 23. Mergers & Acquisitions, Expansion Plans Table 24. Global Factor VIII Deficiency Treatment Market Size by Type (2017-2022) & (US$ Million) Table 25. Global Factor VIII Deficiency Treatment Revenue Market Share by Type (2017-2022) Table 26. Global Factor VIII Deficiency Treatment Forecasted Market Size by Type (2023-2028) & (US$ Million) Table 27. Global Factor VIII Deficiency Treatment Revenue Market Share by Type (2023-2028) Table 28. Global Factor VIII Deficiency Treatment Market Size by Application (2017-2022) & (US$ Million) Table 29. Global Factor VIII Deficiency Treatment Revenue Market Share by Application (2017-2022) Table 30. Global Factor VIII Deficiency Treatment Forecasted Market Size by Application (2023-2028) & (US$ Million) Table 31. Global Factor VIII Deficiency Treatment Revenue Market Share by Application (2023-2028) Table 32. North America Factor VIII Deficiency Treatment Market Size by Country (2017-2022) & (US$ Million) Table 33. North America Factor VIII Deficiency Treatment Market Size by Country (2023-2028) & (US$ Million) Table 34. Europe Factor VIII Deficiency Treatment Market Size by Country (2017-2022) & (US$ Million) Table 35. Europe Factor VIII Deficiency Treatment Market Size by Country (2023-2028) & (US$ Million) Table 36. Asia-Pacific Factor VIII Deficiency Treatment Market Size by Region (2017-2022) & (US$ Million) Table 37. Asia-Pacific Factor VIII Deficiency Treatment Market Size by Region (2023-2028) & (US$ Million) Table 38. Latin America Factor VIII Deficiency Treatment Market Size by Country (2017-2022) & (US$ Million) Table 39. Latin America Factor VIII Deficiency Treatment Market Size by Country (2023-2028) & (US$ Million) Table 40. Middle East & Africa Factor VIII Deficiency Treatment Market Size by Country (2017-2022) & (US$ Million) Table 41. Middle East & Africa Factor VIII Deficiency Treatment Market Size by Country (2023-2028) & (US$ Million) Table 42. Pfizer Company Detail Table 43. Pfizer Business Overview Table 44. Pfizer Factor VIII Deficiency Treatment Product Table 45. Pfizer Revenue in Factor VIII Deficiency Treatment Business (2017-2022) & (US$ Million) Table 46. Pfizer Recent Development Table 47. Takeda Company Detail Table 48. Takeda Business Overview Table 49. Takeda Factor VIII Deficiency Treatment Product Table 50. Takeda Revenue in Factor VIII Deficiency Treatment Business (2017-2022) & (US$ Million) Table 51. Takeda Recent Development Table 52. Bayer HealthCare Company Detail Table 53. Bayer HealthCare Business Overview Table 54. Bayer HealthCare Factor VIII Deficiency Treatment Product Table 55. Bayer HealthCare Revenue in Factor VIII Deficiency Treatment Business (2017-2022) & (US$ Million) Table 56. Bayer HealthCare Recent Development Table 57. CSL Company Detail Table 58. CSL Business Overview Table 59. CSL Factor VIII Deficiency Treatment Product Table 60. CSL Revenue in Factor VIII Deficiency Treatment Business (2017-2022) & (US$ Million) Table 61. CSL Recent Development Table 62. Grifols Company Detail Table 63. Grifols Business Overview Table 64. Grifols Factor VIII Deficiency Treatment Product Table 65. Grifols Revenue in Factor VIII Deficiency Treatment Business (2017-2022) & (US$ Million) Table 66. Grifols Recent Development Table 67. Novo Nordisk Company Detail Table 68. Novo Nordisk Business Overview Table 69. Novo Nordisk Factor VIII Deficiency Treatment Product Table 70. Novo Nordisk Revenue in Factor VIII Deficiency Treatment Business (2017-2022) & (US$ Million) Table 71. Novo Nordisk Recent Development Table 72. F. Hoffmann-La Roche Company Detail Table 73. F. Hoffmann-La Roche Business Overview Table 74. F. Hoffmann-La Roche Factor VIII Deficiency Treatment Product Table 75. F. Hoffmann-La Roche Revenue in Factor VIII Deficiency Treatment Business (2017-2022) & (US$ Million) Table 76. F. Hoffmann-La Roche Recent Development Table 77. Kedrion Company Detail Table 78. Kedrion Business Overview Table 79. Kedrion Factor VIII Deficiency Treatment Product Table 80. Kedrion Revenue in Factor VIII Deficiency Treatment Business (2017-2022) & (US$ Million) Table 81. Kedrion Recent Development Table 82. Octapharma Company Detail Table 83. Octapharma Business Overview Table 84. Octapharma Factor VIII Deficiency Treatment Product Table 85. Octapharma Revenue in Factor VIII Deficiency Treatment Business (2017-2022) & (US$ Million) Table 86. Octapharma Recent Development Table 87. Biogen Idec Company Detail Table 88. Biogen Idec Business Overview Table 89. Biogen Idec Factor VIII Deficiency Treatment Product Table 90. Biogen Idec Revenue in Factor VIII Deficiency Treatment Business (2017-2022) & (US$ Million) Table 91. Biogen Idec Recent Development Table 92. BioMarin Pharmaceutical Company Detail Table 93. BioMarin Pharmaceutical Business Overview Table 94. BioMarin Pharmaceutical Factor VIII Deficiency TreatmentProduct Table 95. BioMarin Pharmaceutical Revenue in Factor VIII Deficiency Treatment Business (2017-2022) & (US$ Million) Table 96. BioMarin Pharmaceutical Recent Development Table 97. Sangamo Therapeutics Company Detail Table 98. Sangamo Therapeutics Business Overview Table 99. Sangamo Therapeutics Factor VIII Deficiency TreatmentProduct Table 100. Sangamo Therapeutics Revenue in Factor VIII Deficiency Treatment Business (2017-2022) & (US$ Million) Table 101. Sangamo Therapeutics Recent Development Table 102. Spark Therapeutics Company Detail Table 103. Spark Therapeutics Business Overview Table 104. Spark Therapeutics Factor VIII Deficiency TreatmentProduct Table 105. Spark Therapeutics Revenue in Factor VIII Deficiency Treatment Business (2017-2022) & (US$ Million) Table 106. Spark Therapeutics Recent Development Table 107. Swedish Orphan Biovitrum Company Detail Table 108. Swedish Orphan Biovitrum Business Overview Table 109. Swedish Orphan Biovitrum Factor VIII Deficiency TreatmentProduct Table 110. Swedish Orphan Biovitrum Revenue in Factor VIII Deficiency Treatment Business (2017-2022) & (US$ Million) Table 111. Swedish Orphan Biovitrum Recent Development Table 112. Uniqure NV Company Detail Table 113. Uniqure NV Business Overview Table 114. Uniqure NV Factor VIII Deficiency TreatmentProduct Table 115. Uniqure NV Revenue in Factor VIII Deficiency Treatment Business (2017-2022) & (US$ Million) Table 116. Uniqure NV Recent Development Table 117. Amarna Therapeutics Company Detail Table 118. Amarna Therapeutics Business Overview Table 119. Amarna Therapeutics Factor VIII Deficiency TreatmentProduct Table 120. Amarna Therapeutics Revenue in Factor VIII Deficiency Treatment Business (2017-2022) & (US$ Million) Table 121. Amarna Therapeutics Recent Development Table 122. Dimension Therapeutics Company Detail Table 123. Dimension Therapeutics Business Overview Table 124. Dimension Therapeutics Factor VIII Deficiency TreatmentProduct Table 125. Dimension Therapeutics Revenue in Factor VIII Deficiency Treatment Business (2017-2022) & (US$ Million) Table 126. Dimension Therapeutics Recent Development Table 127. Research Programs/Design for This Report Table 128. Key Data Information from Secondary Sources Table 129. Key Data Information from Primary Sources List of Figures Figure 1. Global Factor VIII Deficiency Treatment Market Share by Type: 2021 VS 2028 Figure 2. Hemophilia A Drugs Features Figure 3. Hemophilia A Inhibitors Treatment Features Figure 4. Von Willebrand Disease Treatment Features Figure 5. Global Factor VIII Deficiency Treatment Market Share by Application in 2021 & 2028 Figure 6. Hospitals Case Studies Figure 7. Clinics Case Studies Figure 8. Other Case Studies Figure 9. Factor VIII Deficiency Treatment Report Years Considered Figure 10. Global Factor VIII Deficiency Treatment Market Size (US$ Million), Year-over-Year: 2017-2028 Figure 11. Global Factor VIII Deficiency Treatment Market Size, (US$ Million), 2017 VS 2021 VS 2028 Figure 12. Global Factor VIII Deficiency Treatment Market Share by Region: 2021 VS 2028 Figure 13. Global Factor VIII Deficiency Treatment Market Share by Players in 2021 Figure 14. Global Top Factor VIII Deficiency Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Factor VIII Deficiency Treatment as of 2021) Figure 15. The Top 10 and 5 Players Market Share by Factor VIII Deficiency Treatment Revenue in 2021 Figure 16. North America Factor VIII Deficiency Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 17. North America Factor VIII Deficiency Treatment Market Share by Country (2017-2028) Figure 18. United States Factor VIII Deficiency Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 19. Canada Factor VIII Deficiency Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 20. Europe Factor VIII Deficiency Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 21. Europe Factor VIII Deficiency Treatment Market Share by Country (2017-2028) Figure 22. Germany Factor VIII Deficiency Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 23. France Factor VIII Deficiency Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 24. U.K. Factor VIII Deficiency Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 25. Italy Factor VIII Deficiency Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 26. Russia Factor VIII Deficiency Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 27. Nordic Countries Factor VIII Deficiency Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 28. Asia-Pacific Factor VIII Deficiency Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 29. Asia-Pacific Factor VIII Deficiency Treatment Market Share by Region (2017-2028) Figure 30. China Factor VIII Deficiency Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 31. Japan Factor VIII Deficiency Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 32. South Korea Factor VIII Deficiency Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 33. Southeast Asia Factor VIII Deficiency Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 34. India Factor VIII Deficiency Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 35. Australia Factor VIII Deficiency Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 36. Latin America Factor VIII Deficiency Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 37. Latin America Factor VIII Deficiency Treatment Market Share by Country (2017-2028) Figure 38. Mexico Factor VIII Deficiency Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 39. Brazil Factor VIII Deficiency Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 40. Middle East & Africa Factor VIII Deficiency Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 41. Middle East & Africa Factor VIII Deficiency Treatment Market Share by Country (2017-2028) Figure 42. Turkey Factor VIII Deficiency Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 43. Saudi Arabia Factor VIII Deficiency Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 44. Pfizer Revenue Growth Rate in Factor VIII Deficiency Treatment Business (2017-2022) Figure 45. Takeda Revenue Growth Rate in Factor VIII Deficiency Treatment Business (2017-2022) Figure 46. Bayer HealthCare Revenue Growth Rate in Factor VIII Deficiency Treatment Business (2017-2022) Figure 47. CSL Revenue Growth Rate in Factor VIII Deficiency Treatment Business (2017-2022) Figure 48. Grifols Revenue Growth Rate in Factor VIII Deficiency Treatment Business (2017-2022) Figure 49. Novo Nordisk Revenue Growth Rate in Factor VIII Deficiency Treatment Business (2017-2022) Figure 50. F. Hoffmann-La Roche Revenue Growth Rate in Factor VIII Deficiency Treatment Business (2017-2022) Figure 51. Kedrion Revenue Growth Rate in Factor VIII Deficiency Treatment Business (2017-2022) Figure 52. Octapharma Revenue Growth Rate in Factor VIII Deficiency Treatment Business (2017-2022) Figure 53. Biogen Idec Revenue Growth Rate in Factor VIII Deficiency Treatment Business (2017-2022) Figure 54. BioMarin Pharmaceutical Revenue Growth Rate in Factor VIII Deficiency Treatment Business (2017-2022) Figure 55. Sangamo Therapeutics Revenue Growth Rate in Factor VIII Deficiency Treatment Business (2017-2022) Figure 56. Spark Therapeutics Revenue Growth Rate in Factor VIII Deficiency Treatment Business (2017-2022) Figure 57. Swedish Orphan Biovitrum Revenue Growth Rate in Factor VIII Deficiency Treatment Business (2017-2022) Figure 58. Uniqure NV Revenue Growth Rate in Factor VIII Deficiency Treatment Business (2017-2022) Figure 59. Amarna Therapeutics Revenue Growth Rate in Factor VIII Deficiency Treatment Business (2017-2022) Figure 60. Dimension Therapeutics Revenue Growth Rate in Factor VIII Deficiency Treatment Business (2017-2022) Figure 61. Bottom-up and Top-down Approaches for This Report Figure 62. Data Triangulation Figure 63. Key Executives Interviewed

Pfizer Takeda Bayer HealthCare CSL Grifols Novo Nordisk F. Hoffmann-La Roche Kedrion Octapharma Biogen Idec BioMarin Pharmaceutical Sangamo Therapeutics Spark Therapeutics Swedish Orphan Biovitrum Uniqure NV Amarna Therapeutics Dimension Therapeutics